Recruiting Lymphoma Studies in Burlington
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
A multicenter, open-label Phase 2b study of selinexor (KPT-330) in participants with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) who have no therapeutic options of demonstrated cli...
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
This randomized phase II trial studies how well obinutuzumab works as maintenance treatment in patients with central nervous system lymphoma who have achieved the disappearance of all signs of cancer ...
About Lymphoma Clinical Trials in Burlington
Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.
There are currently 2 lymphoma clinical trials recruiting participants in Burlington, VT. These studies are seeking a combined 272 participants. Research is being sponsored by Karyopharm Therapeutics Inc, Providence Health & Services. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lymphoma Clinical Trials in Burlington — FAQ
Are there lymphoma clinical trials in Burlington?
Yes, there are 2 lymphoma clinical trials currently recruiting in Burlington, VT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Burlington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Burlington research site will contact you about next steps.
Are clinical trials in Burlington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Burlington studies also compensate for your time and travel.
What lymphoma treatments are being tested?
The 2 active trials in Burlington are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov